Research Article
Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia
Table 2
Differences in gene expression levels through time in 73 B-ALL patients.
| Gene |
Times included in the comparison and significant values | Time 1/time 2 | Time 1/time 3 | Time 2/time 3 |
| IL2RA | 0.011 | ns | ns | IL10 | 0.012 | ns | ns | CD10 | 0.016 | ns | ns | CD3D | 0.018 | ns | ns | HOXA9 | 0.041 | ns | ns | PAX5 | 0.006 | ns | ns | CTNNB | ns | 0.039 | ns | GSK3B | ns | 0.003 | ns | JAK2 | ns | 0.032 | ns | FOS1 | ns | 0.007 | ns | RAPGEF2 | ns | 0.044 | ns | SORT1 | ns | 0.023 | ns | HK2 | ns | 0.007 | ns | PAX5 | ns | 0.002 | ns | DEFA1 | ns | 0.011 | ns | NOTCH1 | ns | 0.026 | ns | S100A8 | ns | 0.002 | ns | ns | ns | 0.037 | BCL11A | 0.023 | ns | ns | ns | 0.012 | ns | STAT5 | 0.017 | ns | ns | ns | 0.012 | ns | OPAL1 | 0.04 | ns | ns | ns | 0.018 | ns | FLT3 | <0.001 | ns | ns | ns | 0.009 | ns | RXRA | 0.01 | ns | ns | ns | 0.002 | ns | BCL2A | 0.005 | ns | ns | ns | <0.001 | ns | ns | ns | 0.005 |
|
|
ns: nonsignificant, value >0.05.
|